SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-013592
Filing Date
2022-03-18
Accepted
2022-03-18 16:16:04
Documents
104
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_jaspertherap.htm   iXBRL 10-K 1965648
2 DESCRIPTION OF SECURITIES OF JASPER THERAPEUTICS, INC f10k2021ex4-3_jaspertherap.htm EX-4.3 54557
3 CERTIFICATION f10k2021ex31-1_jaspertherap.htm EX-31.1 9960
4 CERTIFICATION f10k2021ex31-2_jaspertherap.htm EX-31.2 9820
5 CERTIFICATION f10k2021ex32-1_jaspertherap.htm EX-32.1 6720
11 GRAPHIC image_001.jpg GRAPHIC 349153
12 GRAPHIC image_002.jpg GRAPHIC 351665
13 GRAPHIC image_003.jpg GRAPHIC 98357
14 GRAPHIC image_004.jpg GRAPHIC 105988
15 GRAPHIC image_005.jpg GRAPHIC 67390
16 GRAPHIC image_006.jpg GRAPHIC 25824
17 GRAPHIC image_007.jpg GRAPHIC 15917
18 GRAPHIC image_008.jpg GRAPHIC 107060
19 GRAPHIC image_009.jpg GRAPHIC 176694
20 GRAPHIC image_010.jpg GRAPHIC 12757
21 GRAPHIC image_011.jpg GRAPHIC 16563
22 GRAPHIC image_012.jpg GRAPHIC 26152
23 GRAPHIC image_013.jpg GRAPHIC 33492
  Complete submission text file 0001213900-22-013592.txt   11401110

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE jspr-20211231.xsd EX-101.SCH 89319
7 XBRL CALCULATION FILE jspr-20211231_cal.xml EX-101.CAL 30726
8 XBRL DEFINITION FILE jspr-20211231_def.xml EX-101.DEF 339465
9 XBRL LABEL FILE jspr-20211231_lab.xml EX-101.LAB 710714
10 XBRL PRESENTATION FILE jspr-20211231_pre.xml EX-101.PRE 355745
98 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_jaspertherap_htm.xml XML 835156
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39138 | Film No.: 22752734
SIC: 2836 Biological Products, (No Diagnostic Substances)